CONFORM Pivotal Trial Site Recruitment Meeting

Published: 16 June 2021

  • Views:

    Views Icon 1217

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

The CONFORM Pivotal Trial is a prospective, multi-center randomized controlled trial, designed to evaluate the safety and effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS®). Subjects will be randomized in a 1:1 fashion between the CLAAS device (treatment) or a Boston Scientific LAA closure device (Control).

 

If interested in participating in the Conform Pivotal Study, please contact Karis Oasan, Clinical Trial Manager koasan@conformalmedical.com.

 

For more information on Conformal Medical, Inc click HERE to visit our website.

This session is a clinical trial recruitment event.

Target Audience

  • Interventional Cardiologists
  • Electrophysiologists
  • All sites specialising in LAA procedures or doing research in this space

More from this programme

Part 1

Welcome and Introductions

Presented by Andy Levine
1 session
Welcome and Introductions Watch now

Part 2

CLAAS Overview

Presented by Dr Aaron Kaplan
1 session
CLAAS Overview Watch now

Part 3

Initial Clinical Experience

Presented by Dr Aaron Kaplan
1 session
Initial Clinical Experience Watch now

Part 4

Case Study and Panel Discussion 1

Presented by Dr William Gray with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi
1 session
Case Study and Panel Discussion 1 Watch now

Part 5

Case Study and Panel Discussion 2

Presented by Dr Vivek Reddy with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi
1 session
Case Study and Panel Discussion 2 Watch now

Part 6

CONFORM Pivotal Trial Summary

Presented by Chris Cain
1 session
CONFORM Pivotal Trial Summary Watch now

Part 7

Closing Remarks

Presented by Dr Aaron Kaplan
1 session
Closing Remarks Watch now

Faculty Biographies

Vivek Reddy

Vivek Reddy

Director of Cardiac Arrhythmia Services

Dr Vivek Y. Reddy is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and Director of Electrophysiology for the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai.

Dr Reddy is one of the US's premier cardiac electrophysiologists. He leads a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias and heart failure, including catheter ablation for atrial fibrillation and ventricular tachycardia, and device therapies for stroke prevention. Under his leadership, Mount Sinai is the lead investigational site for many multinational clinical trials exploring new arrhythmia procedures and technologies, most recently pulsed field ablation to treat atrial fibrillation. Moreover, in 2014, he implanted the world’s first miniature leadless pacemaker, as well as the first leadless pacemaker in…

View full profile